Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells-Reference-Cited by-同舟云学术

Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells

Published:2016-05-26 Issue:26 Volume:7 Page:40362-40376
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Sansan¹²,Chen Xinglu²,Xie Gui’e³,He Yue²,Yan Daoyu²,Zheng Dianpeng²,Li Shi¹,Fu Xinyang¹,Li Yeping¹,Pang Xiang¹,Hu Zhiming²,Li Hongwei²,Tan Wanlong¹,Li Jinlong²

Affiliation:

1. Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

2. Institute of Biotherapy, School of Biotechnology, Southern Medical University, Guangzhou, Guangdong, China

3. KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins;iScience;2024-08

2. Promoter Methylation Changes in DNA Damage-Response Genes in Ovarian Cancer and Their Correlation with Prognosis;Clinical and Experimental Obstetrics & Gynecology;2024-05-10

3. Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments;Nutrition and Cancer;2024-05-09

4. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance;Molecular Cancer;2024-04-29

5. Screening and verification of hub genes in esophageal squamous cell carcinoma by integrated analysis;Scientific Reports;2024-03-22